Archives

  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06

    • Recombinant Mouse Macrophage Colony Stimulating Factor (M...

    2025-12-10

    Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF): Structure, Function, and Research Benchmarks

    Executive Summary: Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF), also called colony stimulating factor 1 (CSF-1), is a four-alpha-helical-bundle cytokine that regulates macrophage survival, proliferation, and differentiation [APExBIO]. M-CSF is essential for osteoclast progenitor maintenance and regulates cytokine release and inflammatory responses (Hu et al., 2025, DOI). The PM2021 product from APExBIO is supplied as a recombinant protein (Lys33-Glu262, ~26 kDa) expressed in HEK293 cells, with >95% purity and biological activity validated in M-NFS-60 cell assays. Quantitative activity is confirmed by an EC50 of 0.2–1.5 pg/mL in a proliferation assay, supporting its use in research on macrophage activation, bone metabolism, and immune signaling. Endotoxin levels are below 0.010 EU/μg, ensuring suitability for sensitive in vitro applications.

    Biological Rationale

    M-CSF is the principal ligand for the c-fms receptor (CSF1R), which is expressed on monocytes, macrophages, and osteoclast progenitors. This cytokine is indispensable for the differentiation and survival of cells in the mononuclear phagocyte system (Hu et al., 2025). In mammals, M-CSF levels rise during pregnancy to facilitate implantation and placental development. It orchestrates immune responses by priming macrophages for enhanced phagocytosis, pinocytosis, and cytokine secretion. Macrophage colony stimulating factor receptor (CSF1R/c-fms) signaling is required for the homeostasis of tissue-resident macrophages and for osteoclast-mediated bone remodeling. Dysregulated M-CSF pathways are implicated in inflammatory diseases, cancer metastasis, and fibrotic pathologies, emphasizing its importance in disease modeling and therapeutic research. APExBIO's PM2021 kit is optimized for precise in vitro investigation of these biological axes.

    Mechanism of Action of Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF)

    Recombinant Mouse M-CSF binds to the c-fms (CSF1R) receptor, a tyrosine kinase expressed predominantly on mononuclear phagocytes. Ligand binding induces receptor dimerization and autophosphorylation, triggering downstream signaling cascades including PI3K-AKT, MAPK, and JAK-STAT pathways. These signals promote macrophage lineage commitment, survival, and functional activation. M-CSF also upregulates genes involved in phagocytosis and inflammatory mediator production. In osteoclast progenitors, M-CSF is required for proliferation and differentiation, acting synergistically with RANKL. At the cellular level, M-CSF-activated macrophages exhibit increased metabolic activity and glycolytic flux, a feature recently linked to fibrotic disease mechanisms (Hu et al., 2025). The recombinant protein's integrity and bioactivity are critical for reproducible receptor engagement and signal transduction in experimental systems.

    Evidence & Benchmarks

    • M-CSF is required for macrophage survival and proliferation in vitro; knockout models exhibit severe macrophage deficiencies (Hu et al., 2025, DOI).
    • Osteoclast progenitor proliferation is strictly M-CSF-dependent; absence leads to osteopetrosis (APExBIO PM2021 datasheet).
    • APExBIO's Recombinant Mouse M-CSF (PM2021) is supplied at 0.2 mg/mL in sterile PBS, with a validated EC50 of 0.2–1.5 pg/mL in M-NFS-60 cell proliferation assays (APExBIO PM2021 datasheet).
    • Endotoxin is controlled below 0.010 EU/μg as measured by the LAL method, ensuring minimal immune confounding in sensitive assays (APExBIO PM2021 datasheet).
    • Macrophage metabolic reprogramming in pulmonary fibrosis is driven by macrophage M2 polarization, which requires M-CSF for maintenance and is linked to glycolytic activation via the IGF2BP1/THBS1/TLR4 axis (Hu et al., 2025, DOI).

    This article updates and extends the coverage of previous summaries of M-CSF's role in macrophage biology by detailing quantitative bioactivity standards and linking recent epigenetic mechanisms in pulmonary fibrosis. For further translational perspectives, see the thought-leadership article on leveraging M-CSF for dissecting macrophage metabolic reprogramming, which this article complements with specific workflow integration parameters.

    Applications, Limits & Misconceptions

    Applications:

    • Macrophage survival, proliferation, and differentiation assays in vitro.
    • Osteoclastogenesis studies and bone metabolism research.
    • Modeling macrophage-mediated inflammatory and fibrotic diseases.
    • Cancer immunology and tumor-associated macrophage (TAM) functional studies.
    • Dissection of c-fms (CSF1R) receptor signaling and endocytosis mechanisms.

    Common Pitfalls or Misconceptions

    • M-CSF alone does not induce complete macrophage activation; co-factors (e.g., LPS, IFN-γ) are often required for functional polarization.
    • Not all myeloid cells respond equivalently to M-CSF; specificity depends on CSF1R expression.
    • M-CSF is not suitable for direct therapeutic administration in humans; the PM2021 product is strictly for research use only.
    • Repeated freeze-thaw cycles degrade protein activity; always aliquot and store at -20 to -70°C.
    • The product is not validated for diagnostic or clinical applications.

    Workflow Integration & Parameters

    APExBIO's Recombinant Mouse M-CSF (PM2021) is delivered as a ready-to-use solution in sterile PBS at 0.2 mg/mL. It should be stored at -20 to -70°C, protected from light, and aliquoted to avoid repeated freeze-thaw cycles. The protein is validated for activity using M-NFS-60 mouse myelogenous leukemia lymphoblast cells, with an EC50 typically between 0.2–1.5 pg/mL in proliferation assays. For in vitro differentiation of bone marrow-derived macrophages, concentrations between 10–100 ng/mL are commonly used, though optimization is required based on cell type, assay, and experimental design. Endotoxin levels are below 0.010 EU/μg, minimizing risk of unwanted inflammatory activation. Purity is confirmed by SDS-PAGE (>95%). The product is shipped on dry ice and maintains stability for up to 3 years from date of receipt. Refer to the official product page for lot-specific documentation and handling instructions.

    Conclusion & Outlook

    Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) is a cornerstone reagent for dissecting macrophage biology, osteoclastogenesis, and immune modulation. The PM2021 product from APExBIO offers validated purity, low endotoxin, and robust bioactivity benchmarks, making it suitable for cutting-edge research in cancer, inflammation, and fibrosis. Recent findings highlight the importance of macrophage metabolic reprogramming in disease processes, with M-CSF-dependent pathways central to these mechanisms (Hu et al., 2025). As new molecular insights and therapeutic strategies emerge, precise and reproducible cytokine reagents like PM2021 will remain essential tools for experimental and translational research.